![So Chu Chang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
So Chu Chang
Voorzitter bij VECTORITE BIOMEDICAL INC.
Oorsprong van het eerstegraads netwerk van So Chu Chang
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Other Transportation | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met So Chu Chang via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Graduate Degree | |
University of British Columbia | College/University | Doctorate Degree | |
University of Tamkang | College/University | Undergraduate Degree | |
National Taiwan University | College/University | Graduate Degree | |
National Cheng Kung University | College/University | Graduate Degree | |
Soochow University /Taiwan/ | College/University | Undergraduate Degree | |
UWELL Biopharma, Inc.
![]() UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
Taiwan | 6 |
Verenigde Staten | 2 |
Canada | 2 |
Sectoraal
Consumer Services | 7 |
Health Technology | 2 |
Operationeel
Director/Board Member | 7 |
Independent Dir/Board Member | 4 |
Graduate Degree | 3 |
Undergraduate Degree | 2 |
Comptroller/Controller/Auditor | 2 |
Sterkste connecties
- Beurs
- Insiders
- So Chu Chang
- Bedrijfsconnecties